Brief: EQL Pharma Says Mellozzan Has Been Approved In Italy
25/03/2026 10:17
March 25 (Reuters) - EQL Pharma AB EQL.ST: MELLOZZAN® (MELATONIN) HAS BEEN APPROVED IN ITALY EQL'S KEY PRODUCT MELLOZZAN® HAS NOW RECEIVED MARKETING AUTHORIZATION APPROVAL FROM HEALTH AUTHORITY IN ITALY (AIFA) LAUNCH OF MELLOZZAN® IN ITALY IS EXPECTED IN END OF FISCAL YEAR 2026/27 OR EARLY 2027/28 Source text: ID:nWkr8khmVw Further company coverage: EQL.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))